/*!*********************************************************************************
 * X2Engine Open Source Edition is a customer relationship management program developed by
 * X2 Engine, Inc. Copyright (C) 2011-2017 X2 Engine Inc.
 * 
 * This program is free software; you can redistribute it and/or modify it under
 * the terms of the GNU Affero General Public License version 3 as published by the
 * Free Software Foundation with the addition of the following permission added
 * to Section 15 as permitted in Section 7(a): FOR ANY PART OF THE COVERED WORK
 * IN WHICH THE COPYRIGHT IS OWNED BY X2ENGINE, X2ENGINE DISCLAIMS THE WARRANTY
 * OF NON INFRINGEMENT OF THIRD PARTY RIGHTS.
 * 
 * This program is distributed in the hope that it will be useful, but WITHOUT
 * ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS
 * FOR A PARTICULAR PURPOSE.  See the GNU Affero General Public License for more
 * details.
 * 
 * You should have received a copy of the GNU Affero General Public License along with
 * this program; if not, see http://www.gnu.org/licenses or write to the Free
 * Software Foundation, Inc., 51 Franklin Street, Fifth Floor, Boston, MA
 * 02110-1301 USA.
 * 
 * You can contact X2Engine, Inc. P.O. Box 610121, Redwood City,
 * California 94061, USA. or at email address contact@x2engine.com.
 * 
 * The interactive user interfaces in modified source and object code versions
 * of this program must display Appropriate Legal Notices, as required under
 * Section 5 of the GNU Affero General Public License version 3.
 * 
 * In accordance with Section 7(b) of the GNU Affero General Public License version 3,
 * these Appropriate Legal Notices must retain the display of the "Powered by
 * X2 Engine" logo. If the display of the logo is not reasonably feasible for
 * technical reasons, the Appropriate Legal Notices must display the words
 * "Powered by X2 Engine".
 **********************************************************************************/#content{background:none !important;border:none !important}#report-container{margin-top:5px}#report-settings .x2-pill-box>.x2-pill.sort-by-pill>select{margin:0;font-size:10px;margin-left:6px}#order-by-pill-box,#group-by-pill-box{min-height:32px}#aggregates-pill-box{min-height:32px}#aggregates-pill-box .aggregate-fn-checkboxes-container{margin-left:5px;display:inline-block}#aggregates-pill-box .aggregate-fn-checkboxes-container>input{position:relative;top:3px;margin-left:2px;margin-right:3px;margin-top:0;margin-bottom:0}#aggregates-pill-box span.aggregate-fn-checkboxes-container>label{display:inline-block;position:relative;top:-1px}#generated-report .subgrid-expand-button-container{padding:0 !important}td.subgrid-expand-button-container>button.x2-button{width:10px;margin:0;padding:0;width:100%;height:100%;border-radius:0;border-top:none;border-bottom:none;border-right:none;box-sizing:border-box;background:inherit;font-size:16px;color:#7c7c7c;border-left:none}#generated-report .x2grid-body-grips,#generated-report.drill-down-grid .x2grid-grips>div:first-child{display:none}.x2-subgrid .x2grid-body-grips,.x2-subgrid .x2grid-grips>div:first-child{display:block !important}.x2-subgrid-row>td{padding:0 !important;padding-left:26px !important}.x2-subgrid-top-bar{height:24px;background:gainsboro;border-bottom:1px solid #bbbbbb}.x2-subgrid{border-left:1px solid #c5c5c5}.x2-subgrid .x2grid-body-container>.grid-report-items{border-bottom:1px solid #c5c5c5 !important}.x2-subgrid .x2grid-header-container>.grid-report-items{border-bottom:none !important}.x2-subgrid .empty-pager.pager{display:none}.x2-subgrid .summary{margin-top:2px}
